S. A. Kaye

Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout (2003)

Feher, M. D., Hepburn, A. L., Hogarth, M. B., Ball, S. G., Kaye, S. A.

Objective. To assess the short‐term urate‐lowering effect of fenofibrate in men on long‐term allopurinol therapy for hyperuricaemia and gout. Methods. Ten male patients...

SMALL BOWEL BACTERIAL OVERGROWTH IN SYSTEMIC SCLEROSIS: DETECTION USING DIRECT AND INDIRECT METHODS AND TREATMENT OUTCOME (1995)

KAYE, S.A., LIM, S. G., TAYLOR, M., PATEL, S., GILLESPIE, S., BLACK, C. M.

Twenty-four patients with proven systemic sclerosis and with symptoms suggestive of malabsorption (i.e. chronic diarrhoea and weight loss) were investigated for small bowel bacterial overgrowth. Of...

Ischaemia of the small intestine in patients with systemic sclerosis: Raynaud's phenomenon or chronic vasculopathy? (1994)

KAYE, S.A., SEIFALIAN, A.M., LIM, S.G., HAMILTON, G., BLACK, C.M.

We investigated duodenal and gastric mucosal blood flow by endoscopic laser Doppler flowmetery (LDF) in ten patients with systemic sclerosis (SSc) and in ten healthy volunteers. In addition, we...

Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.

Louise, C B, Kaye, S A, Boyd, B, Lingwood, C A, Obrig, T G

Escherichia coli O157:H7-related vascular damage such as hemolytic uremic syndrome is believed to require the Shiga-like toxins. This study demonstrated that sodium butyrate sensitized human...

Characterization of Pseudomonas aeruginosa mutants that are deficient in exotoxin A synthesis and are altered in expression of regA, a positive regulator of exotoxin A.

West, S E, Kaye, S A, Hamood, A N, Iglewski, B H

In Pseudomonas aeruginosa, production of exotoxin A, an ADP-ribosyltransferase, is a complex and highly regulated process. Two positively acting regulatory genes, regA and regB, have been cloned and...

Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.

Kaye, S A, Louise, C B, Boyd, B, Lingwood, C A, Obrig, T G

Development of hemolytic uremic syndrome (HUS) after infection by Shigella dysenteriae 1 or enterohemorrhagic Escherichia coli has been associated with the production of Shiga toxins (verotoxins)....

Infertility linked to breast cancer.

Folsom, A R, Sellers, T A, Kaye, S A

Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.

Louise, C B, Kaye, S A, Boyd, B, Lingwood, C A, Obrig, T G

Escherichia coli O157:H7-related vascular damage such as hemolytic uremic syndrome is believed to require the Shiga-like toxins. This study demonstrated that sodium butyrate sensitized human...

Characterization of Pseudomonas aeruginosa mutants that are deficient in exotoxin A synthesis and are altered in expression of regA, a positive regulator of exotoxin A.

West, S E, Kaye, S A, Hamood, A N, Iglewski, B H

In Pseudomonas aeruginosa, production of exotoxin A, an ADP-ribosyltransferase, is a complex and highly regulated process. Two positively acting regulatory genes, regA and regB, have been cloned and...

Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.

Kaye, S A, Louise, C B, Boyd, B, Lingwood, C A, Obrig, T G

Development of hemolytic uremic syndrome (HUS) after infection by Shigella dysenteriae 1 or enterohemorrhagic Escherichia coli has been associated with the production of Shiga toxins (verotoxins)....

Infertility linked to breast cancer.

Folsom, A R, Sellers, T A, Kaye, S A